Baird Medical Investment Holdings Limited
BDMD
$3.16
$0.02450.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 87.59% | 0.00% | -47.29% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -5.25% | 0.00% | -0.64% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 2,096.45% | 0.00% | -95.47% | 0.00% |
| Change in Net Operating Assets | 0.00% | -37.74% | 0.00% | 24.12% | 0.00% |
| Cash from Operations | 0.00% | 40.59% | 0.00% | -138.15% | 0.00% |
| Capital Expenditure | 0.00% | -388.61% | 0.00% | 64.72% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -388.61% | 0.00% | 64.72% | 0.00% |
| Total Debt Issued | 0.00% | 66.26% | 0.00% | -1.03% | 0.00% |
| Total Debt Repaid | 0.00% | -105.57% | 0.00% | 22.42% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 200.00% | 0.00% | -130.79% | 0.00% |
| Cash from Financing | 0.00% | 40.53% | 0.00% | 10.88% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -271.00% | 0.00% | -19.05% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 18,447.50% | 0.00% | -100.83% | 0.00% |